B., Chan, G
The STEP trials for semaglutide 2.4 mg (Wegovy) showed: Average weight loss of approximately 15% of body weight over 68 weeks One-third of participants lost 20% or more of body weight Significant reductions in waist circumference, blood pressure, and cardiovascular risk markers The SURMOUNT trials for tirzepatide (Zepbound) showed even more impressive results: Average weight loss of 20-25% at the highest dose (15 mg) over 72 weeks More than half of participants lost 20% or more of body weight Significant improvements in type 2 diabetes markers, blood pressure, and lipid profiles The head-to-head comparison is clear
For peptide reconstitution, the bacteriostatic water should be added slowly to the lyophilized peptide vial, directed against the glass wall rather than directly onto the peptide cake
This would be a very direct and powerful test of the hypothesis, Beaudet said
And if thats the case and Im on my death bed in a year, I wont regret how hard Ive worked to try to live a longer, better life
So if youre feeling discouraged and overwhelmed about what your diet should be on GLP-1s, you arent alone